NextCure Inc NXTC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/03/24 EDT
1.53quote price arrow up+0.04 (+2.68%)
Volume
89,582
52 week range
0.98 - 2.57
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.53
  • 52 Week High2.57
  • 52 Week High Date04/02/24
  • 52 Week Low0.98
  • 52 Week Low Date10/25/23

Key Stats

  • Market Cap42.799M
  • Shares Out27.97M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta0.55
  • YTD % Change34.21

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.53
  • 52 Week High2.57
  • 52 Week High Date04/02/24
  • 52 Week Low0.98
  • 52 Week Low Date10/25/23
  • Market Cap42.799M
  • Shares Out27.97M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta0.55
  • YTD % Change34.21

RATIOS/PROFITABILITY

  • EPS (TTM)-2.29
  • P/E (TTM)-0.67
  • Fwd P/E (NTM)-0.94
  • EBITDA (TTM)-63.953M
  • ROE (TTM)-44.49%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-163.57%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On NextCure Inc

 

Profile

MORE
NextCure, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on advancing medicines that treat cancer patients that do not respond to, or have disease progression on, current therapies, through the use of differentiated mechanisms of actions including Antibody-Drug Conjugates (ADCs), antibodies, and proteins. The Company focuses on advancing therapies that leverage its core strengths in understanding biological pathways and biomarkers, the interactions...
David Kabakoff Ph.D.
Independent Chairman of the Board
Michael Richman
President, Chief Executive Officer, Director
Timothy Mayer Ph.D.
Chief Operating Officer
Steven Cobourn CPA
Chief Financial Officer
Address
9000 Virginia Manor Rd Ste 200
Beltsville, MD
20705-4214
United States

Top Peers

SYMBOLLASTCHG%CHG
CKPT
Checkpoint Therapeutics Inc
1.58+0.10+6.76%
XLO
Xilio Therapeutics Inc
1.18+0.13+12.38%
ACXP
Acurx Pharmaceuticals Inc
2.17+0.05+2.36%
INKT
Mink Therapeutics Inc
0.98+0.0106+1.0935%
EFTR
eFFECTOR Therapeutics Inc
2.20+0.04+1.85%